Potential shortage of 140,000 nurses in NHS England by 2030
July 20, 2022Research and Development
According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …
TSB and CR Pharma partner for COVID-19 antibody therapy in China
July 20, 2022Research and Development
TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …
Brain cancer treatment receives Orphan Drug Designation
July 19, 2022Manufacturing and Production
The FDA has granted an Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of …
MIT research demonstrates potential of self-boosting vaccines
July 19, 2022Manufacturing and Production
In a new study, MIT researchers describe the analysis of a release mechanism from biodegradable core-shell microparticles.Through understanding how and …
New reforms aim for better NHS dental service access
July 19, 2022Manufacturing and Production
Patients across the country will benefit from improved access to dental care under changes announced by NHS England, the organisation …
WHO to assist Ghana following confirmed Marburg cases
July 19, 2022Manufacturing and Production
WHO has announced that in the coming days it will deploy a team of experts to assist Ghana in tackling …
FDA approval for neurostimulation device to treat diabetic neuropathic pain
July 15, 2022Medical Communications
DyAnsys has received FDA approval for its First Relief device, a wearable device monitoring pulses of a low-level electrical current …
Step strategy effective in treating diabetic eye disease
July 15, 2022Medical Communications
An NIH-funded clinical from the DRCR Retina Network suggests that a specific step strategy for patients with diabetic macular edema …
FDA approves new treatment for rare tumour
July 15, 2022Medical Communications
The FDA has approved crizotinib for adult and paediatric patients aged 1 year and older with unresectable, recurrent, or refractory …
First immunotherapy for untreated, unresectable malignant pleural mesothelioma recommended by NICE
July 14, 2022Business Services
Bristol Myers Squibb (BMS) has announced that the NICE Final Appraisal Document (FAD) recommending the combination of nivolumab plus ipilimumab …
Trodelvy recommended in England for metastatic triple negative breast cancer
July 14, 2022Business Services
Gilead Sciences has announced the NICE recommendation of Trodelvy (sacituzumab govitecan) for use on the NHS in England, as an …
Nucleai partners with Sirona Dx for AI-driven discovery of biomarkers in solid tumours
July 14, 2022Business Services
Nuclei and Sirona Dx have announced a collaboration to advance the discovery of novel spatial biomarkers in solid tumours.The partnership …
Gene editing potential treatment for hereditary killer
July 13, 2022Research and Development
Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …
FDA accepts Byondis’ Biologics License Application for breast cancer treatment
July 13, 2022Research and Development
The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with …
Trial of mRNA first Nipah virus vaccine
July 13, 2022Research and Development
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage …
Health organisations warn monkeypox could become endemic in UK if action is not taken
July 13, 2022Research and Development
Leading sexual health organisations have warned that monkeypox could become endemic in the UK if the government does not take …
FDA approves Lipocine’s IND for adult epilepsy treatment
July 12, 2022Manufacturing and Production
The FDA has accepted Lipocine’s Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a …
NIH grant for research into functional cure for HIV
July 12, 2022Manufacturing and Production
The NIH has granted Oregon Health and Science Univerity (OHSU) a $5 million grant for the research of its one-time …
Vasopharm GmbH announces positive data from clinical trials in traumatic brain injury
July 12, 2022Manufacturing and Production
Vasopharm GmbH has announced the results of significantly reduced brain microdialyse lactate levels in the Phase II (NOSTRA) and Phase …
Application to FDA for first-ever over-the-counter birth control pill
July 12, 2022Manufacturing and Production
The FDA is due to consider whether oral birth control medication should be made available to consumers over the counter, …
